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Two mixed crystals were obtained by crystallizing the active pharmaceutical
ingredient pyridoxine [systematic name: 4,5-bis(hydroxymethyl)-2-methylpyri-
din-3-ol, PN] with (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid (feru-
lic acid) and 4-hydroxy-3,5-dimethoxybenzoic acid (syringic acid). PN and the
coformers crystallize in the form of pharmaceutical salts in a 1:1 stoichiometric





+C10H11O5H2O, the proton exchange
between PN and the acidic partner being supported by the differences of the
pKa values of the two components and by the C—O bond lengths of the
carboxylate groups. Besides complex hydrogen-bonding networks, – inter-
actions between aromatic moieties have been found to be important for the
packing architecture in both crystals. Hirshfeld surface analysis was used to
explore the intermolecular interactions in detail and compare them with the
interactions found in similar pyridoxine/carboxylic acid salts.
1. Introduction
Multicomponent solids, designed by applying crystal engi-
neering tools, have been, and continue to be, an active ﬁeld of
research in many areas dealing with functional materials. In
particular, in the last decade, pharmaceutical chemists have
expended a great deal of effort in synthesizing new crystalline
phases, called pharmaceutical cocrystals (PCCs), where at
least one component is an active pharmaceutical ingredient
(API). PCCs are generally classiﬁed as mixed crystals in which
a drug and other substances (coformers) present in neutral
form cocrystallize in a stoichiometric ratio and are held
together by intermolecular interactions, in such a way as to
maintain unaltered the chemical structure of the API and
hence its pharmacological proﬁle. The increasing interest in
PCCs is due to the fact that they display intermolecular motifs
and crystal structures different from the pure API components
and consequently can exhibit diverse speciﬁc physical prop-
erties, e.g. API dissolution rate and solubility (Nehm et al.,
2006; Good & Rodrı´guez-Hornedo, 2009; Goud et al., 2012),
API pharmacokinetics (Cheney et al., 2010; Shan et al., 2014;
Suresh et al., 2014, 2016), bioavailability (Bak et al., 2008; Jung
et al., 2010) and permeability (Ferretti et al., 2015; Dalpiaz et
al., 2017), efﬁciency and safety of the API native solid form,
available in pharmaceutical formulations, and processability
and stability of the sole crystalline form of PCC with a unique
structure (Newman & Wenslow, 2016; Battini et al., 2014;
Trask, 2007) in comparison with all the solid forms in which
the API may exist (Morissette et al., 2004; Almarsson et al.,
2003). For these reasons, both the United States Food and
ISSN 2053-2296
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Drug Administration (US FDA) and the European Medicines
Agency (EMA) have delivered position documents about
PCCs attesting the growing interest of their use in drug
products and providing guidance to industry (FDA, 2016;
EMA, 2014).
In continuation of our interest in this ﬁeld (Cvetkovski et
al., 2016; Cvetkovski & Ferretti, 2016), we have initiated a
project on the synthesis of PCCs using the API pyridoxine and
aromatic acids. Pyridoxine (henceforth referred to as PN), in
the form of an alcohol derivative of pyridine, is one of three
members of the vitamin B6 family. The other two members,
the aldehyde form pyridoxal and an amine form pyridox-
amine, are known as pseudopyridoxines (Urbanski, 1949).
These three forms are derivatives of -hydroxypyridine; the
presence of the pyridine ring is a structural characteristic
shared with other vitamins of group B, i.e. nicotinic acid and
nicotinamide (niacin, vitamin B3), obtained by substituting
the -position with a carboxylic acid or amide group (Mooney
et al., 2009). Due to the presence of a basic N atom (PN pKa =
5.1; Santos et al., 2010), pyridoxine can easily form salts with
acidic molecules and, in fact, is mainly commercialized as
pyridoxine hydrochloride.
The coformers selected for the present study were ferulic
and syringic acids, belonging to the class of nutraceutic acids,
whose pKa1 values are 4.27 (Erdemgil et al., 2007) and 3.86
(Chuysinuan et al., 2009), respectively. According to the so-
called ‘rule of three’, when synthesizing a mixed crystal, a salt
is expected if pKa [pKa(base) – pKa(acid)] is greater than 2 or 3
units, while the formation of a cocrystal is observed if pKa is
less than 0 (Childs et al., 2007; Bhogala et al., 2005). pKa
ranging between 0 and 2 or 3 is generally considered to indi-
cate a salt–cocrystal continuum, so that it was not possible to
predict a priori the formation of a salt or a cocrystal. The
structures presented here for 3-hydroxy-4,5-bis(hydroxy-
methyl)-2-methylpyridin-1-ium 4-hydroxy-3,5-dimethoxyben-
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Crystal system, space group Triclinic, P1 Monoclinic, P21
Temperature (K) 295 295
a, b, c (A˚) 6.9085 (2), 8.4524 (2), 17.9702 (5) 7.2440 (3), 17.1615 (5), 7.2706 (2)
, ,  () 101.8010 (16), 92.7110 (16), 109.8290 (14) 90, 98.806 (2), 90
V (A˚3) 958.47 (5) 893.21 (5)
Z 2 2
Radiation type Mo K Mo K
 (mm1) 0.10 0.11
Crystal size (mm) 0.52  0.20  0.09 0.35  0.22  0.13
Data collection
Diffractometer Nonius KappaCCD Nonius KappaCCD
No. of measured, independent and observed
[I > 2(I)] reﬂections





R[F 2 > 2(F 2)], wR(F 2), S 0.053, 0.167, 1.06 0.040, 0.108, 1.07
No. of reﬂections 4387 4578
No. of parameters 256 272
No. of restraints 0 1
H-atom treatment H atoms treated by a mixture of independent
and constrained reﬁnement





3) 0.38, 0.27 0.27, 0.18
Absolute structure – Flack x determined using 1452 quotients
[(I+)  (I)]/[(I+) + (I)] (Parsons et al., 2013)
Absolute structure parameter – 0.4 (4)
Computer programs: COLLECT (Nonius, 1997), DENZO-SMN (Otwinowski & Minor, 1997), SIR97 (Altomare et al., 1999), ORTEPIII (Burnett & Johnson, 1996), MarvinSketch
(ChemAxon, 2010), SHELXL2014 (Sheldrick, 2015) and WinGX (Farrugia, 2012).
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zoate, (1), and 3-hydroxy-4,5-bis(hydroxymethyl)-2-methyl-
pyridin-1-ium (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-
oate monohydrate, (2), are both molecular salts.
2. Experimental
2.1. Synthesis and crystallization
Pyridoxine, the other cocrystal formers and the solvents
were purchased from Sigma–Aldrich and were used without
further puriﬁcation. All chemicals were of analytical or
chromatographic grade.
2.1.1. Synthesis of pharmaceutical salt (1). The sediment of
single crystals of PN–syringic acid (SYR) were prepared by
slow evaporation from the isopropanol solution obtained after
ﬁltration of the slurry containing PN hydrochloride (173 mg)
neutralized with sodium hydroxide (33.6 mg) (1:1 molar ratio)
and syringic acid (166.7 mg) (PN neutral form–syringic acid in
a 1:1 molar ratio) in isopropanol (20 ml).
2.1.2. Synthesis of pharmaceutical salt (2). Colourless
needle-shaped single crystals of the PN–ferulic acid (FER) salt
were grown by slow evaporation from the clear solution
obtained after ﬁltration of the slurry prepared by mixing PN
hydrochloride (68.63 mg) and sodium hydroxide (13.3 mg)
(1:1 molar ratio) with feluric acid (64.8 mg) (PN neutral form/
base–ferulic acid in a 1:1 molar ratio) in a mixture of iso-
propanol and acetonitrile (15 ml, 1:1 v/v).
2.2. Data collection and refinement
Crystal data, data collection and structure reﬁnement
details are summarized in Table 1. In salt (1), the electron-
density difference map showed some rather large broad peaks
located in the centre of the unit cell. Attempts to identify the
solvent molecules failed. Instead, a new set of F2 (hkl) values
with the contribution from solvent molecules withdrawn was
obtained using the SQUEEZE procedure (Spek, 2015)
implemented in PLATON (Spek, 2009). The potential solvent
volume in the crystals is ca 124 A˚3 per unit-cell volume. In
both structures, H atoms bound to N or O atoms were located
in difference Fourier maps and reﬁned isotropically, whereas
H atoms bonded to C atoms were included at idealized posi-
tions and allowed to ride on their respective C atoms. The
arene and methylene H atoms were constrained with C—H =
0.93 A˚ [Uiso(H) = 1.2Ueq(C)] and the methyl H atoms with
C—H = 0.96 A˚ [Uiso(H) = 1.5Ueq(C)].
2.3. Hirshfeld surfaces and fingerprints evaluation
Molecular Hirshfeld surfaces (Hirshfeld, 1977) and their 2D
(two-dimensional) ﬁngerprint plots (Spackman & McKinnon,
2002; McKinnon et al., 2007) have been evaluated in order to
gain additional insight into the network of intermolecular
interactions in the crystals. The Hirshfeld surface represents
the molecule when interacting with the crystal environment
and the decomposition of this surface gives a ‘molecular
ﬁngerprint’, i.e. a 2D map indicating which intermolecular
interactions are present and the relative area of the surface
corresponding to each kind of interaction. The Hirshfeld
surfaces and 2D ﬁngerprint plots were generated using
CrystalExplorer 3.0 (Wolff et al., 2012).
3. Results and discussion
The crystal of (1) (Fig. 1) is composed of cationic PN moieties,
i.e. pyridoxinium, and syringate anions in a 1:1 stoichiometric
ratio, as well as cocrystallized solvent molecules (vide supra),
while the asymmetric unit of (2) (Fig. 2) is composed by one
pyridoxinium cation, one ferulate anion and one water mol-
ecule in a 1:1:1 stoichiometric ratio. According to the ‘rule of
three’, the pKa values of the PN–ferulic acid (0.83) and PN–
syringic acid (1.24) pairs are in the so-called ‘salt–cocrystal
continuum’ region. In both structures, proton transfer from
the carboxylic acid group to the basic pyridine N atom of the
drug molecule is conﬁrmed by (i) the delocalization of the –
COO group, in terms of bond length and angle equalization
[C—O = 1.235 (2) and 1.275 (2) A˚ in (1), and 1.253 (3) and
1.267 (3) A˚ in (2); C—C—O = 116.84 (16) and 118.93 (16) in
(1) and 118.83 (17) and 118.69 (17) in (2)], and (ii) the values
of the C1—N1—C5 bond angles, which are wider than those
research papers
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Figure 1
The molecular structure and atom-numbering scheme for (1), with
displacement ellipsoids drawn at the 40% probability level. Hydrogen
bonds are drawn as dashed lines.
Figure 2
The molecular structure and atom-numbering scheme for (2), with
displacement ellipsoids drawn at the 40% probability level. Hydrogen
bonds are drawn as dashed lines.
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found in unprotonated pyridines [123.59 (14) in (1) and
123.26 (18) in (2)].
The pyridoxinium cations are characterized by an intra-
molecular O3—H3O  O2 hydrogen bond, while the proto-
nated N atom forms a strong N—H  O interaction with the
coformer carboxylate group, whose short N  O distance is
typical of charge-assisted hydrogen bonds (Table 2). Due to
the plethora of good donor and acceptor groups, the
hydrogen-bonding network appears to be rather complicated
in both structures. In salt (1), the molecules are arranged in
planar layers (in the bc plane), forming R44(20) and R
4
4(30)
adjacent rings, marked as A and B, respectively, in Fig. 3.
These parallel layers are stacked along the a direction and
linked through O2—H2O  O4iii hydogen bonds, with the
possible involvement of the cocrystallized solvent molecules
(vide supra). Indeed, the solvent is located in tunnels running
along the a direction, as shown in Fig. 4(a). Layers are also
formed in salt (2); in this case, the role played by the cocrys-
tallized water molecule in joining adjacent layers is evident,
acting both as hydrogen-bonding donor (towards O6 and O7)
and acceptor (from O1). The unit-cell contents, viewed along
the b axis, are shown in Fig. 5(a). It is worth noting that,
besides hydrogen bonding, in both structures, – interactions
contribute to the robustness of the crystal (Table 2 and Figs. 4b
and 5b). In both structures, drug/coformer mixed columns with
heterogeneous interstack separations (Andre´ et al., 1997) are
research papers
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Figure 3
R44(20) (denoted A) and R
4
4(30) (denoted B) rings formed in the bc plane
of (1). Hydrogen bonds are drawn as dashed lines.
Figure 4
(a) The empty space in (1), viewed in projection along the a axis. (b) The
crystal projection showing the molecular stacking.
Table 2
Structural parameters for hydrogen-bond and – interactions (A˚, ) for
(1) and (2).
Cg represents a ring centroid.
D—H  A D—H D  A H  A D—H  A
Cocrystal (1)
N1—H1N  O4 0.91 (2) 2.671 (2) 1.77 (2) 171 (2)
O3—H3O  O2 0.95 (4) 2.663 (2) 1.83 (4) 144 (3)
C8—H8A  O4 0.96 3.308 (2) 2.52 139
C1—H1  O1i 0.93 3.359 (2) 2.47 158
O1—H1O  O5i 0.85 (3) 2.663 (2) 1.83 (3) 166 (3)
C6—H6B  O5ii 0.97 3.576 (3) 2.64 161
O2—H2O  O4iii 0.87 (4) 2.620 (2) 1.77 (4) 165 (3)
O7—H7O  O2iv 0.89 (2) 2.728 (1) 1.93 (2) 146 (3)
Cg(C10–C15)  Cg(N1/C1–C5)v 3.552
Cg(C10–C15)  Cg(N1/C1–C5)vi 3.577
Cocrystal (2)
N1—H1N  O5 0.93 (4) 2.641 (2) 1.73 (5) 166 (4)
O3—H3O  O2 0.90 (5) 2.564 (3) 1.68 (5) 165 (4)
O1W–H2W  O5 0.90 (5) 2.893 (3) 2.02 (5) 161 (5)
C8—H8A  O5 0.96 3.307 (3) 2.51 140
O2—H2O  O1vii 0.91 (6) 2.747 (3) 1.84 (6) 171 (5)
C8—H8C  O4vii 0.96 3.541 (3) 2.63 158
C17—H17  O1W viii 0.93 3.472 (3) 2.55 167
O6—H6O  O4ix 0.94 (4) 2.545 (2) 1.62 (4) 166 (4)
O1—H1O  O1Wx 0.86 (3) 2.683 (3) 1.82 (3) 175 (3)
O1W—H1W  O6x 0.82 (5) 2.896 (2) 2.12 (5) 156 (4)
O1W—H1W  O7x 0.82 (5) 2.994 (3) 2.37 (5) 132 (4)
Cg(C12–C17)  Cg(N1/C1–C5)xi 3.608
Cg(C12–C17)  Cg(N1/C1–C5)xii 3.671
Symmetry codes: (i) x, y + 1, z; (ii) x + 1, y + 1, z; (iii) x, y + 1, z; (iv) x  1, y  2, z;
(v) x 1, y 1, z; (vi) x, y 1, z; (vii) x, y, z + 1; (viii) x, y, z 1; (ix)x + 1, y + 12,z + 1;
(x) x + 1, y  12, z + 2; (xi) x + 1, y + 12, z + 2; (xii) x + 2, y + 12, z + 2.
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formed. In salt (1), neighbouring aromatic rings of PN and
syringic acid molecules are stacked at centroid–centroid
(Cg  Cg) distances of 3.552 and 3.577 A˚ in an almost parallel
way, the mean dihedral angle between two adjacent molecules
being 2.6. Along the columns, the centroids of the aromatic
rings are only slightly shifted, as shown by the angles formed
by the Cg!Cg vector and the normal to the plane of one ring
(13.5 and 16.2). In (2), the Cg  Cg distances become larger,
due to the fact that the molecular layers are more puckered
than in (1). Indeed, while the dihedral angle between two
adjacent molecules is very similar (1.3), the angles formed by
the Cg!Cg vector and the normal to plane of one ring are
larger, being 15.9 and 21.9. Calculations concerning –
interactions were performed using PLATON (Spek, 2009).
A comparison can be made with an analogous series of PN
cocrystals/salts published recently (Ganduri et al., 2015),
where the coformers are 4-amino-, 4-hydroxy-, 4-cyano- and
4-nitrobenzoic acids. To better visualize and analyze all
intermolecular interactions, Hirshfeld surfaces (HS) and their
corresponding 2D ﬁngergerprint plots (Hirshfeld, 1977;
Spackman & McKinnon, 2002; McKinnon et al., 2007) have
been generated. The surfaces and plots of the PN molecule in
(1) and (2) are shown in Figs. 6 and 7, respectively. The
function mapped onto the Hirshfeld surface is dnorm, i.e. the
normalized contact distance, deﬁned in terms of de (distance
to the nearest atoms outside), di (distance to the nearest atoms
inside) and the van der Waals (vdW) radii of the two atoms
external and internal to the surface; the red regions represent
distances shorter than the sum of the vdW radii, while the
white-coloured regions correspond to weak contacts and the
blue-coloured regions are considered to be free of signiﬁcant
contacts. When the values of di and de for any HS surface point
are plotted against each other, a ﬁngerprint plot is obtained.
Here, the different colours are related to the density of points
giving that particular di – de combination; for high density, the
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Figure 5
(a) The unit-cell contents of (2), viewed along the b axis. Hydrogen bonds are drawn as dashed lines. (b) The crystal projection showing the molecular
stacking.
Figure 6
Hirshfeld surface and ﬁngerprint plot for the PN molecule in (1).
Figure 7
Hirshfeld surface and ﬁngerprint plot for the PN molecule in (2).
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colour is red, for moderate density the colour is green and for
relatively few points the colour is blue. It is also possible to
highlight on the plot a single contact of the type atom-
type1  atomtype2, to focus attention on the individual
interaction types present (Spackman & Jayatilaka, 2009).
The surface coloured according to dnorm (0.72 to 1.25 A˚)
values shows where the short intermolecular interactions
occur; in particular, the red spot corresponding to the inter-
action with the carboxylate group is represented in the
ﬁngerprints plot by the end of the sharper upper spike in both
structures (Figs. 6 and 7); in this zone, the contribution of the
O—H  O hydrogen bond involving the O1—H PN hydroxy
group is also added. The lower spike corresponds instead to
O7—H7O  O2iv and O2—H2O  O1vii in (1) and (2),
respectively, i.e. hydrogen bonds where PN is acting as the
acceptor molecule. The central marker present in both
ﬁngerprint plots, formed by C  C and C  N interactions, is a
typical and characteristic hint towards signiﬁcant – inter-
actions (Spackman & Jayatilaka, 2009). Examination of
decomposed 2D ﬁngerprint plots shows that the percentage of
intermolecular H  O interactions is very similar in the two
salts, viz. 36.1 and 29.8%, respectively. The ﬁngerprint plots of
the PN molecule present in the literature salts mentioned
above are shown in Fig. 8. The ﬁngerprint plots of both the
aminobenzoate and hydroxybenzoate salts (Figs. 8a and 8b)
show some similarities with the present structures, in parti-
cular, as far as the two sharp spikes are concerned. Indeed,
they refer to similar O/N—H  O interactions, with N  O
and O  O distances in the ranges 2.66–2.76 and 2.65–2.90 A˚,
respectively. In nitro- and cyanobenzoate salts, the lower spike
is much less evident (Figs. 8c and 8d). Due to the lack of good
hydrogen-bonding donor groups in the coformer molecule, in
fact, they mark the existence of weaker C—H  O inter-
actions. The differences visible in the ﬁngerprint plots shown
in Fig. 8 may result also from different stacking types, i.e.
heterogeneous in parts (a) and (b) and homogeneous in part
(c). Moreover, in the case of cyanobenzoate (Fig. 8d), the
aromatic rings are stacked at a distance greater than 4 A˚ and
accordingly no marker appears in the ﬁngerprint plot. These
ﬁndings, besides indicating the robustness of the pyridine/
carboxylic acid supramolecular synthon, point to its impor-
tance in driving the assembly process of different cocrystal
units.
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Computing details 
For both structures, data collection: COLLECT (Nonius, 1997); cell refinement: DENZO-SMN (Otwinowski & Minor, 
1997); data reduction: DENZO-SMN (Otwinowski & Minor, 1997); program(s) used to solve structure: SIR97 (Altomare 
et al., 1999); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015); molecular graphics: ORTEPIII 
(Burnett & Johnson, 1996) and MarvinSketch (ChemAxon, 2010); software used to prepare material for publication: 
SHELXL2014 (Sheldrick, 2015) and WinGX (Farrugia, 2012).






a = 6.9085 (2) Å
b = 8.4524 (2) Å
c = 17.9702 (5) Å
α = 101.8010 (16)°
β = 92.7110 (16)°
γ = 109.8290 (14)°
V = 958.47 (5) Å3
Z = 2
F(000) = 388
Dx = 1.273 Mg m−3
Mo Kα radiation, λ = 0.71073 Å
Cell parameters from 18203 reflections
θ = 3–27°
µ = 0.10 mm−1
T = 295 K
Plate, colourless




φ scans and ω scans
18203 measured reflections
4387 independent reflections
3191 reflections with I > 2σ(I)
Rint = 0.035













Hydrogen site location: mixed
H atoms treated by a mixture of independent 
and constrained refinement
w = 1/[σ2(Fo2) + (0.0972P)2 + 0.1657P] 
where P = (Fo2 + 2Fc2)/3
(Δ/σ)max < 0.001
Δρmax = 0.38 e Å−3
Δρmin = −0.27 e Å−3
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Extinction correction: SHELXL2014 
(Sheldrick, 2015), 
Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Extinction coefficient: 0.049 (12)
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance 
matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; 
correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate 
(isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq
N1 0.0285 (2) 0.59703 (18) 0.20164 (8) 0.0356 (3)
O1 0.1171 (3) 0.72836 (18) −0.00103 (9) 0.0750 (6)
O2 0.2464 (2) 1.24197 (14) 0.27041 (7) 0.0437 (3)
O3 0.2151 (2) 0.99184 (17) 0.34344 (7) 0.0500 (4)
O4 −0.0942 (2) 0.26847 (15) 0.21330 (8) 0.0491 (4)
O5 −0.2842 (3) 0.0993 (2) 0.10465 (8) 0.0679 (5)
O6 −0.3275 (2) −0.10970 (16) 0.40501 (7) 0.0571 (4)
O7 −0.4868 (2) −0.42453 (16) 0.32123 (7) 0.0503 (4)
O8 −0.5267 (2) −0.49958 (15) 0.16857 (7) 0.0530 (4)
C1 0.0551 (2) 0.6461 (2) 0.13492 (10) 0.0355 (4)
H1 0.0187 0.5630 0.0888 0.043*
C2 0.1360 (3) 0.8185 (2) 0.13488 (9) 0.0352 (4)
C3 0.1906 (2) 0.9421 (2) 0.20504 (10) 0.0351 (4)
C4 0.1620 (3) 0.8850 (2) 0.27271 (10) 0.0358 (4)
C5 0.0775 (3) 0.7085 (2) 0.27035 (9) 0.0358 (4)
C6 0.1681 (3) 0.8730 (2) 0.06041 (10) 0.0484 (5)
H6A 0.0821 0.9399 0.0530 0.058*
H6B 0.3118 0.9460 0.0622 0.058*
C7 0.2845 (3) 1.1324 (2) 0.20618 (12) 0.0475 (5)
H7A 0.4332 1.1639 0.2061 0.057*
H7B 0.2289 1.1520 0.1597 0.057*
C8 0.0449 (3) 0.6418 (3) 0.34144 (11) 0.0504 (5)
H8A −0.0269 0.5188 0.3277 0.076*
H8B −0.0361 0.6959 0.3719 0.076*
H8C 0.1769 0.6680 0.3704 0.076*
C9 −0.2191 (3) 0.1241 (2) 0.17279 (11) 0.0406 (4)
C10 −0.2906 (2) −0.0230 (2) 0.21191 (9) 0.0344 (4)
C11 −0.3779 (3) −0.1917 (2) 0.16787 (9) 0.0359 (4)
H11 −0.3938 −0.2134 0.1147 0.043*
C12 −0.4411 (3) −0.3270 (2) 0.20417 (9) 0.0352 (4)
C13 −0.4236 (3) −0.2945 (2) 0.28378 (9) 0.0361 (4)
C14 −0.3377 (3) −0.1254 (2) 0.32759 (9) 0.0374 (4)
C15 −0.2698 (3) 0.0107 (2) 0.29161 (10) 0.0368 (4)
H15 −0.2106 0.1239 0.3206 0.044*
C16 −0.5400 (4) −0.5445 (3) 0.08700 (11) 0.0617 (6)
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H16A −0.4507 −0.4482 0.0697 0.093*
H16B −0.6805 −0.5734 0.0650 0.093*
H16C −0.4978 −0.6422 0.0715 0.093*
C17 −0.2404 (5) 0.0579 (3) 0.45295 (13) 0.0834 (9)
H17A −0.1217 0.1245 0.4326 0.125*
H17B −0.1986 0.0504 0.5034 0.125*
H17C −0.3415 0.1130 0.4554 0.125*
H1O 0.155 (4) 0.770 (4) −0.0395 (17) 0.080 (8)*
H2O 0.123 (5) 1.243 (4) 0.2578 (18) 0.097 (10)*
H3O 0.252 (5) 1.108 (4) 0.3378 (18) 0.102 (10)*
H1N −0.019 (3) 0.482 (3) 0.2007 (11) 0.046 (5)*
H7O −0.554 (4) −0.525 (4) 0.2870 (16) 0.074 (8)*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
N1 0.0409 (7) 0.0255 (7) 0.0409 (8) 0.0094 (6) 0.0070 (6) 0.0128 (6)
O1 0.1270 (15) 0.0346 (7) 0.0400 (8) −0.0016 (8) 0.0173 (9) 0.0095 (6)
O2 0.0503 (8) 0.0241 (6) 0.0490 (7) 0.0076 (5) 0.0025 (6) 0.0024 (5)
O3 0.0740 (9) 0.0329 (7) 0.0379 (7) 0.0146 (6) 0.0051 (6) 0.0049 (5)
O4 0.0563 (8) 0.0271 (6) 0.0626 (8) 0.0084 (5) 0.0065 (6) 0.0191 (6)
O5 0.0870 (11) 0.0577 (9) 0.0480 (8) 0.0022 (8) 0.0044 (7) 0.0303 (7)
O6 0.0896 (11) 0.0348 (7) 0.0301 (6) 0.0022 (7) 0.0041 (6) 0.0066 (5)
O7 0.0725 (9) 0.0283 (6) 0.0394 (7) 0.0005 (6) 0.0056 (6) 0.0150 (5)
O8 0.0810 (10) 0.0268 (6) 0.0364 (7) 0.0030 (6) 0.0077 (6) 0.0035 (5)
C1 0.0388 (8) 0.0284 (8) 0.0376 (8) 0.0086 (6) 0.0059 (7) 0.0095 (6)
C2 0.0376 (8) 0.0292 (8) 0.0393 (9) 0.0105 (6) 0.0070 (7) 0.0113 (7)
C3 0.0383 (8) 0.0251 (7) 0.0432 (9) 0.0111 (6) 0.0095 (7) 0.0104 (6)
C4 0.0428 (8) 0.0277 (8) 0.0369 (8) 0.0132 (7) 0.0048 (7) 0.0070 (6)
C5 0.0427 (9) 0.0293 (8) 0.0374 (8) 0.0133 (7) 0.0056 (7) 0.0116 (6)
C6 0.0672 (12) 0.0320 (9) 0.0423 (10) 0.0094 (8) 0.0113 (9) 0.0136 (7)
C7 0.0585 (11) 0.0251 (8) 0.0588 (11) 0.0121 (8) 0.0202 (9) 0.0117 (8)
C8 0.0719 (13) 0.0418 (10) 0.0416 (10) 0.0195 (9) 0.0106 (9) 0.0194 (8)
C9 0.0429 (9) 0.0353 (9) 0.0478 (10) 0.0123 (7) 0.0134 (7) 0.0199 (7)
C10 0.0348 (8) 0.0288 (8) 0.0399 (9) 0.0082 (6) 0.0070 (6) 0.0134 (6)
C11 0.0401 (8) 0.0332 (8) 0.0328 (8) 0.0086 (7) 0.0073 (6) 0.0112 (6)
C12 0.0390 (8) 0.0272 (8) 0.0339 (8) 0.0050 (6) 0.0041 (6) 0.0070 (6)
C13 0.0416 (8) 0.0266 (8) 0.0365 (8) 0.0052 (6) 0.0057 (7) 0.0115 (7)
C14 0.0451 (9) 0.0303 (8) 0.0312 (8) 0.0058 (7) 0.0048 (7) 0.0083 (6)
C15 0.0411 (8) 0.0242 (7) 0.0400 (9) 0.0049 (6) 0.0055 (7) 0.0082 (6)
C16 0.0843 (15) 0.0441 (11) 0.0381 (10) 0.0057 (10) 0.0084 (10) −0.0012 (8)
C17 0.136 (2) 0.0461 (12) 0.0380 (11) 0.0031 (14) 0.0042 (13) −0.0030 (9)
Geometric parameters (Å, º) 
N1—C5 1.340 (2) C5—C8 1.495 (2)
N1—C1 1.347 (2) C6—H6A 0.9700
N1—H1N 0.91 (2) C6—H6B 0.9700
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O1—C6 1.399 (2) C7—H7A 0.9700
O1—H1O 0.85 (3) C7—H7B 0.9700
O2—C7 1.420 (2) C8—H8A 0.9600
O2—H2O 0.87 (3) C8—H8B 0.9600
O3—C4 1.352 (2) C8—H8C 0.9600
O3—H3O 0.95 (3) C9—C10 1.503 (2)
O4—C9 1.275 (2) C10—C11 1.390 (2)
O5—C9 1.235 (2) C10—C15 1.393 (2)
O6—C14 1.366 (2) C11—C12 1.385 (2)
O6—C17 1.409 (2) C11—H11 0.9300
O7—C13 1.3626 (19) C12—C13 1.392 (2)
O7—H7O 0.90 (3) C13—C14 1.391 (2)
O8—C12 1.3727 (19) C14—C15 1.389 (2)
O8—C16 1.427 (2) C15—H15 0.9300
C1—C2 1.372 (2) C16—H16A 0.9600
C1—H1 0.9300 C16—H16B 0.9600
C2—C3 1.405 (2) C16—H16C 0.9600
C2—C6 1.505 (2) C17—H17A 0.9600
C3—C4 1.396 (2) C17—H17B 0.9600
C3—C7 1.512 (2) C17—H17C 0.9600
C4—C5 1.396 (2)
C5—N1—C1 123.59 (14) H8A—C8—H8B 109.5
C5—N1—H1N 117.5 (13) C5—C8—H8C 109.5
C1—N1—H1N 118.8 (13) H8A—C8—H8C 109.5
C6—O1—H1O 104.7 (19) H8B—C8—H8C 109.5
C7—O2—H2O 105 (2) O5—C9—O4 124.23 (16)
C4—O3—H3O 108.1 (19) O5—C9—C10 118.93 (16)
C14—O6—C17 117.84 (15) O4—C9—C10 116.84 (16)
C13—O7—H7O 109.3 (17) C11—C10—C15 120.72 (14)
C12—O8—C16 117.14 (14) C11—C10—C9 119.43 (15)
N1—C1—C2 120.10 (15) C15—C10—C9 119.85 (15)
N1—C1—H1 120.0 C12—C11—C10 119.23 (15)
C2—C1—H1 120.0 C12—C11—H11 120.4
C1—C2—C3 119.16 (15) C10—C11—H11 120.4
C1—C2—C6 120.06 (15) O8—C12—C11 125.88 (15)
C3—C2—C6 120.77 (14) O8—C12—C13 113.64 (14)
C4—C3—C2 118.66 (14) C11—C12—C13 120.47 (15)
C4—C3—C7 121.44 (15) O7—C13—C14 118.00 (15)
C2—C3—C7 119.87 (15) O7—C13—C12 121.94 (15)
O3—C4—C5 115.73 (15) C14—C13—C12 120.06 (14)
O3—C4—C3 123.78 (15) O6—C14—C15 125.48 (15)
C5—C4—C3 120.48 (15) O6—C14—C13 114.76 (14)
N1—C5—C4 118.00 (15) C15—C14—C13 119.77 (15)
N1—C5—C8 119.78 (14) C14—C15—C10 119.72 (15)
C4—C5—C8 122.21 (15) C14—C15—H15 120.1
O1—C6—C2 110.61 (14) C10—C15—H15 120.1
O1—C6—H6A 109.5 O8—C16—H16A 109.5
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C2—C6—H6A 109.5 O8—C16—H16B 109.5
O1—C6—H6B 109.5 H16A—C16—H16B 109.5
C2—C6—H6B 109.5 O8—C16—H16C 109.5
H6A—C6—H6B 108.1 H16A—C16—H16C 109.5
O2—C7—C3 113.71 (14) H16B—C16—H16C 109.5
O2—C7—H7A 108.8 O6—C17—H17A 109.5
C3—C7—H7A 108.8 O6—C17—H17B 109.5
O2—C7—H7B 108.8 H17A—C17—H17B 109.5
C3—C7—H7B 108.8 O6—C17—H17C 109.5
H7A—C7—H7B 107.7 H17A—C17—H17C 109.5
C5—C8—H8A 109.5 H17B—C17—H17C 109.5
C5—C8—H8B 109.5
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A
N1—H1N···O4 0.91 (2) 1.77 (2) 2.671 (2) 171 (2)
O3—H3O···O2 0.95 (4) 1.83 (4) 2.663 (2) 144 (3)
C8—H8A···O4 0.96 2.52 3.308 (2) 139
C1—H1···O1i 0.93 2.47 3.359 (2) 158
O1—H1O···O5i 0.85 (3) 1.83 (3) 2.663 (2) 166 (3)
C6—H6B···O5ii 0.97 2.64 3.576 (3) 161
O2—H2O···O4iii 0.87 (4) 1.77 (4) 2.620 (2) 165 (3)
O7—H7O···O2iv 0.89 (2) 1.93 (2) 2.728 (1) 146 (3)







a = 7.2440 (3) Å
b = 17.1615 (5) Å
c = 7.2706 (2) Å
β = 98.806 (2)°
V = 893.21 (5) Å3
Z = 2
F(000) = 404
Dx = 1.418 Mg m−3
Mo Kα radiation, λ = 0.71073 Å
Cell parameters from 11173 reflections
θ = 4–30°
µ = 0.11 mm−1
T = 295 K
Prismatic, colourless
0.35 × 0.22 × 0.13 mm
Data collection 
Nonius Kappa CCD 
diffractometer
φ scans and ω scans
11173 measured reflections
4578 independent reflections
3822 reflections with I > 2σ(I)
Rint = 0.034
















Hydrogen site location: mixed
H atoms treated by a mixture of independent 
and constrained refinement
w = 1/[σ2(Fo2) + (0.063P)2 + 0.0278P] 
where P = (Fo2 + 2Fc2)/3
(Δ/σ)max < 0.001
Δρmax = 0.27 e Å−3
Δρmin = −0.18 e Å−3
Absolute structure: Flack x determined using 
1452 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et 
al., 2013)
Absolute structure parameter: −0.4 (4)
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance 
matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; 
correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate 
(isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq
N1 0.8860 (3) −0.19960 (10) 1.1832 (2) 0.0354 (4)
O1 0.7016 (3) −0.39465 (12) 0.8941 (2) 0.0551 (5)
O2 0.9773 (4) −0.40722 (13) 1.6750 (3) 0.0622 (6)
O3 1.0560 (3) −0.26271 (12) 1.6424 (2) 0.0526 (4)
O4 0.7236 (2) −0.12996 (9) 0.7844 (2) 0.0457 (4)
O5 0.8366 (3) −0.05993 (9) 1.0310 (2) 0.0473 (4)
O6 0.4671 (3) 0.36773 (9) 0.5400 (2) 0.0492 (4)
O7 0.6240 (3) 0.35956 (10) 0.8823 (2) 0.0565 (5)
O1W 0.5731 (3) 0.00760 (11) 1.2468 (2) 0.0502 (4)
C1 0.8257 (3) −0.26552 (12) 1.0932 (3) 0.0352 (4)
H1 0.7760 −0.2635 0.9675 0.042*
C2 0.8367 (3) −0.33573 (12) 1.1852 (3) 0.0325 (4)
C3 0.9116 (3) −0.33702 (12) 1.3759 (3) 0.0331 (4)
C4 0.9767 (3) −0.26757 (13) 1.4613 (3) 0.0356 (4)
C5 0.9623 (3) −0.19785 (12) 1.3625 (3) 0.0352 (4)
C6 0.7702 (3) −0.40987 (12) 1.0846 (3) 0.0384 (4)
H6A 0.8727 −0.4467 1.0934 0.046*
H6B 0.6719 −0.4330 1.1434 0.046*
C7 0.9194 (4) −0.41369 (14) 1.4799 (3) 0.0466 (5)
H7A 0.7965 −0.4374 1.4580 0.056*
H7B 1.0047 −0.4483 1.4291 0.056*
C8 1.0285 (4) −0.12139 (15) 1.4478 (3) 0.0464 (5)
H8A 1.0056 −0.0810 1.3557 0.070*
H8B 1.1599 −0.1243 1.4931 0.070*
H8C 0.9622 −0.1098 1.5492 0.070*
C9 0.7545 (3) −0.06564 (11) 0.8646 (3) 0.0332 (4)
C10 0.6902 (3) 0.00681 (12) 0.7617 (3) 0.0368 (4)
H10 0.6318 0.0027 0.6390 0.044*
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C11 0.7130 (3) 0.07718 (12) 0.8386 (3) 0.0332 (4)
H11 0.7754 0.0793 0.9602 0.040*
C12 0.6508 (3) 0.15162 (11) 0.7528 (3) 0.0320 (4)
C13 0.6705 (3) 0.21921 (12) 0.8628 (3) 0.0349 (4)
H13 0.7248 0.2159 0.9871 0.042*
C14 0.6101 (3) 0.29043 (12) 0.7888 (3) 0.0365 (4)
C15 0.5249 (3) 0.29579 (12) 0.6022 (3) 0.0363 (4)
C16 0.5067 (3) 0.22952 (12) 0.4926 (3) 0.0370 (4)
H16 0.4518 0.2330 0.3686 0.044*
C17 0.5697 (3) 0.15779 (12) 0.5661 (3) 0.0365 (4)
H17 0.5578 0.1137 0.4907 0.044*
C18 0.7096 (4) 0.35938 (16) 1.0716 (3) 0.0537 (6)
H18A 0.6440 0.3241 1.1411 0.081*
H18B 0.7053 0.4109 1.1221 0.081*
H18C 0.8373 0.3430 1.0797 0.081*
H1N 0.879 (5) −0.153 (3) 1.116 (5) 0.080 (11)*
H1O 0.614 (4) −0.428 (2) 0.855 (4) 0.046 (7)*
H2O 0.877 (8) −0.403 (3) 1.737 (7) 0.115 (18)*
H3O 1.038 (6) −0.313 (3) 1.674 (6) 0.081 (12)*
H6O 0.396 (5) 0.360 (3) 0.422 (6) 0.080 (11)*
H1W 0.537 (6) −0.035 (3) 1.282 (6) 0.078 (11)*
H2W 0.674 (7) −0.007 (3) 1.196 (6) 0.100 (14)*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
N1 0.0409 (9) 0.0269 (8) 0.0361 (8) 0.0026 (7) −0.0010 (7) 0.0031 (7)
O1 0.0745 (13) 0.0494 (10) 0.0396 (9) −0.0207 (10) 0.0032 (8) −0.0049 (8)
O2 0.0801 (14) 0.0624 (13) 0.0422 (9) −0.0019 (11) 0.0025 (9) 0.0191 (9)
O3 0.0712 (12) 0.0515 (10) 0.0313 (7) 0.0014 (9) −0.0048 (7) −0.0008 (7)
O4 0.0667 (10) 0.0267 (7) 0.0392 (8) 0.0019 (7) −0.0061 (7) −0.0014 (6)
O5 0.0688 (11) 0.0296 (7) 0.0376 (8) 0.0047 (7) −0.0103 (7) 0.0000 (6)
O6 0.0712 (11) 0.0276 (8) 0.0419 (8) 0.0069 (8) −0.0129 (7) 0.0032 (6)
O7 0.0924 (13) 0.0285 (8) 0.0404 (8) 0.0096 (9) −0.0163 (8) −0.0027 (7)
O1W 0.0700 (12) 0.0332 (8) 0.0473 (9) 0.0067 (8) 0.0082 (8) 0.0033 (7)
C1 0.0406 (10) 0.0300 (9) 0.0333 (9) 0.0005 (9) −0.0001 (8) 0.0016 (8)
C2 0.0336 (10) 0.0292 (9) 0.0345 (9) 0.0019 (8) 0.0047 (7) 0.0000 (8)
C3 0.0360 (10) 0.0309 (9) 0.0330 (9) 0.0039 (8) 0.0079 (7) 0.0029 (8)
C4 0.0398 (10) 0.0366 (10) 0.0296 (9) 0.0051 (9) 0.0030 (7) 0.0021 (8)
C5 0.0368 (10) 0.0331 (10) 0.0348 (9) 0.0010 (9) 0.0021 (8) −0.0023 (8)
C6 0.0443 (11) 0.0310 (10) 0.0399 (10) −0.0038 (9) 0.0066 (8) −0.0031 (8)
C7 0.0655 (15) 0.0356 (11) 0.0404 (11) 0.0078 (11) 0.0135 (10) 0.0098 (9)
C8 0.0552 (13) 0.0369 (11) 0.0440 (11) −0.0023 (10) −0.0017 (9) −0.0060 (9)
C9 0.0392 (10) 0.0262 (9) 0.0333 (9) 0.0041 (8) 0.0025 (7) 0.0028 (7)
C10 0.0450 (11) 0.0296 (9) 0.0333 (9) 0.0015 (9) −0.0017 (8) 0.0030 (8)
C11 0.0349 (10) 0.0289 (9) 0.0347 (9) 0.0010 (8) 0.0020 (7) 0.0036 (8)
C12 0.0331 (10) 0.0255 (9) 0.0365 (9) 0.0000 (8) 0.0022 (7) 0.0032 (8)
C13 0.0405 (10) 0.0296 (10) 0.0323 (9) 0.0009 (8) −0.0017 (7) 0.0020 (8)
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C14 0.0426 (11) 0.0280 (10) 0.0366 (10) −0.0003 (9) −0.0014 (8) −0.0014 (8)
C15 0.0414 (11) 0.0293 (9) 0.0360 (10) 0.0020 (9) −0.0005 (8) 0.0059 (8)
C16 0.0438 (11) 0.0312 (9) 0.0333 (9) −0.0003 (9) −0.0030 (8) 0.0031 (8)
C17 0.0431 (11) 0.0293 (9) 0.0354 (9) 0.0000 (9) 0.0009 (8) 0.0006 (8)
C18 0.0772 (17) 0.0407 (12) 0.0377 (11) 0.0052 (12) −0.0088 (11) −0.0075 (10)
Geometric parameters (Å, º) 
N1—C5 1.336 (3) C6—H6A 0.9700
N1—C1 1.346 (3) C6—H6B 0.9700
N1—H1N 0.93 (5) C7—H7A 0.9700
O1—C6 1.423 (3) C7—H7B 0.9700
O1—H1O 0.87 (3) C8—H8A 0.9600
O2—C7 1.421 (3) C8—H8B 0.9600
O2—H2O 0.92 (5) C8—H8C 0.9600
O3—C4 1.356 (2) C9—C10 1.488 (3)
O3—H3O 0.91 (5) C10—C11 1.330 (3)
O4—C9 1.253 (3) C10—H10 0.9300
O5—C9 1.267 (3) C11—C12 1.462 (3)
O6—C15 1.359 (3) C11—H11 0.9300
O6—H6O 0.94 (4) C12—C17 1.398 (3)
O7—C14 1.363 (3) C12—C13 1.404 (3)
O7—C18 1.421 (3) C13—C14 1.379 (3)
O1W—H1W 0.82 (5) C13—H13 0.9300
O1W—H2W 0.90 (5) C14—C15 1.405 (3)
C1—C2 1.374 (3) C15—C16 1.383 (3)
C1—H1 0.9300 C16—C17 1.391 (3)
C2—C3 1.409 (3) C16—H16 0.9300
C2—C6 1.509 (3) C17—H17 0.9300
C3—C4 1.393 (3) C18—H18A 0.9600
C3—C7 1.514 (3) C18—H18B 0.9600
C4—C5 1.391 (3) C18—H18C 0.9600
C5—C8 1.498 (3)
C5—N1—C1 123.26 (18) H8A—C8—H8B 109.5
C5—N1—H1N 118 (2) C5—C8—H8C 109.5
C1—N1—H1N 118 (2) H8A—C8—H8C 109.5
C6—O1—H1O 109.4 (19) H8B—C8—H8C 109.5
C7—O2—H2O 111 (3) O4—C9—O5 122.47 (18)
C4—O3—H3O 98 (3) O4—C9—C10 118.83 (17)
C15—O6—H6O 106 (3) O5—C9—C10 118.69 (17)
C14—O7—C18 117.98 (18) C11—C10—C9 122.54 (17)
H1W—O1W—H2W 102 (4) C11—C10—H10 118.7
N1—C1—C2 120.66 (18) C9—C10—H10 118.7
N1—C1—H1 119.7 C10—C11—C12 127.11 (18)
C2—C1—H1 119.7 C10—C11—H11 116.4
C1—C2—C3 118.51 (19) C12—C11—H11 116.4
C1—C2—C6 120.87 (18) C17—C12—C13 118.80 (18)
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C3—C2—C6 120.62 (18) C17—C12—C11 122.46 (18)
C4—C3—C2 118.58 (18) C13—C12—C11 118.73 (17)
C4—C3—C7 122.45 (18) C14—C13—C12 120.74 (18)
C2—C3—C7 118.97 (19) C14—C13—H13 119.6
O3—C4—C5 115.8 (2) C12—C13—H13 119.6
O3—C4—C3 123.4 (2) O7—C14—C13 125.58 (18)
C5—C4—C3 120.81 (17) O7—C14—C15 114.36 (18)
N1—C5—C4 118.13 (18) C13—C14—C15 120.06 (18)
N1—C5—C8 118.81 (19) O6—C15—C16 123.92 (18)
C4—C5—C8 123.06 (18) O6—C15—C14 116.62 (19)
O1—C6—C2 110.78 (17) C16—C15—C14 119.45 (18)
O1—C6—H6A 109.5 C15—C16—C17 120.63 (19)
C2—C6—H6A 109.5 C15—C16—H16 119.7
O1—C6—H6B 109.5 C17—C16—H16 119.7
C2—C6—H6B 109.5 C16—C17—C12 120.29 (19)
H6A—C6—H6B 108.1 C16—C17—H17 119.9
O2—C7—C3 114.4 (2) C12—C17—H17 119.9
O2—C7—H7A 108.7 O7—C18—H18A 109.5
C3—C7—H7A 108.7 O7—C18—H18B 109.5
O2—C7—H7B 108.7 H18A—C18—H18B 109.5
C3—C7—H7B 108.7 O7—C18—H18C 109.5
H7A—C7—H7B 107.6 H18A—C18—H18C 109.5
C5—C8—H8A 109.5 H18B—C18—H18C 109.5
C5—C8—H8B 109.5
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A
N1—H1N···O5 0.93 (4) 1.73 (5) 2.641 (2) 166 (4)
O3—H3O···O2 0.90 (5) 1.68 (5) 2.564 (3) 165 (4)
O1W—H2W···O5 0.90 (5) 2.02 (5) 2.893 (3) 161 (5)
C8—H8A···O5 0.96 2.51 3.307 (3) 140
O2—H2O···O1i 0.91 (6) 1.84 (6) 2.747 (3) 171 (5)
C8—H8C···O4i 0.96 2.63 3.541 (3) 158
C17—H17···O1Wii 0.93 2.55 3.472 (3) 167
O6—H6O···O4iii 0.94 (4) 1.62 (4) 2.545 (2) 166 (4)
O1—H1O···O1Wiv 0.86 (3) 1.82 (3) 2.683 (3) 175 (3)
O1W—H1W···O6iviv 0.82 (5) 2.12 (5) 2.896 (2) 156 (4)
O1W—H1W···O7iviv 0.82 (5) 2.37 (5) 2.994 (3) 132 (4)
Symmetry codes: (i) x, y, z+1; (ii) x, y, z−1; (iii) −x+1, y+1/2, −z+1; (iv) −x+1, y−1/2, −z+2.
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